Glyconanoparticle Pharmacokinetic Study Service
Overview
In the biomedical field, glyconanoparticles are highly sought after for their unique biocompatibility, targeting, and drug-delivery capabilities. CD BioGlyco provides reliable Glyconanoparticle Development, Characterization, and Preclinical Study services. We provide pharmacokinetic study services for glyconanoparticles to gain an in-depth understanding of their behavior in vivo and in vitro, including key processes such as absorption, distribution, metabolism, excretion, and half-life.
Uncovering Glyconanoparticles: An In-Depth Look at Pharmacokinetics
Pharmacokinetics is the science of quantitatively studying the dynamics of drug absorption, distribution, metabolism, and excretion in living organisms, and elucidating the relationship between drug concentration at different sites and time. We have abundant In Vitro Models and In Vivo Models for glyconanoparticle pharmacokinetic studies.
Our company evaluates the absorption efficiency of glyconanoparticles in different tissues or organs by simulating physiological conditions, providing data support for the optimization of the drug delivery system.
Our company utilizes advanced imaging techniques and bioanalytical methods to track the distribution pathways of glyconanoparticles, revealing their targeting and tissue penetration capabilities.
Metabolism Study
Our company provides services to analyze the metabolic pathways and metabolites of glyconanoparticles in living organisms, and to assess their effects and potential toxicity on biological systems.
Excretion Study
Our company provides excretion monitoring services for glyconanoparticles, including urinary, fecal, and other excretion routes, to provide support for drug safety and pharmacokinetic parameters.
Half-life Study
Our company determines the half-life of glyconanoparticles by monitoring their concentration in the body over time, which is critical for evaluating drug duration and dose design.
We have an experienced research team and a specialized GlycoNano™ Platform with powerful testing and analysis capabilities to perform a wide range of flexible tests. Specific services include the following:
In Vitro Studies
- The active substance in glyconanoparticles is only effective if it is released at a specific site and binds to its target. Therefore, we look at the cell as a microscopic organism and study the mode of entry of glyconanoparticles into the cell and the intracellular and subcellular drug content at the target site.
- Our researchers provide kinetic analysis of glyconanoparticle uptake, transport, distribution, metabolism, and excretion in the cell, and elucidate the disposition of glyconanoparticles in the cell through mathematical modeling, which helps clients to comprehensively elucidate the mechanism of action of glyconanoparticles in the cell.
In Vivo Studies
- Tissue ultrastructure distribution and blood biochemical index: Our company provides many types of animal models for pharmacokinetic studies such as mouse, rat, guinea pig, rabbit, and monkey. Our researchers measure the distribution of glyconanoparticles in various organs of animals, blood concentration-time profiles, and effects on blood biochemical indices by collecting blood and organs after glyconanoparticle injection.
- Analysis of factors influencing the in vivo pharmacokinetics of glyconanoparticles: Our lab mainly provides effect analysis of particle size, surface charge, surface properties, and particle shape on in vivo pharmacokinetics of glyconanoparticles.
Workflow

Applications
- Glyconanoparticle pharmacokinetic study can be used to optimize the drug delivery system of glyconanoparticles to improve drug efficacy and bioavailability.
- Glyconanoparticle pharmacokinetic study can be used to evaluate the safety and potential toxicity of glyconanoparticles to provide a basis for safety evaluation.
- Glyconanoparticle pharmacokinetic study can be used to analyze the distribution and concentration of glyconanoparticles in vivo and predict the efficacy of drugs.
Advantages of Us
- We provide pharmacokinetic services not only for in vivo drug efficacy but also for cellular/subcellular pharmacokinetic studies, which help to elucidate more comprehensively the mechanism of action in cells.
- Our company designs and conducts in vivo and in vitro pharmacokinetic tests according to client needs and provides personalized services.
- Our company has an experienced research team with a deep background in glycobiology and nanotechnology. Not only do we customize the raw materials for nanoparticles but also combine different types of carbohydrates.
Publication Data
Technology: Fourier transform infrared (FTIR) spectra, Nuclear magnetic resonance (NMR), Transmission electron microscope (TEM), High-performance liquid chromatography (HPLC)
Journal: Pharmaceutics
Published: 2022
IF: 4.9
Results: In this study, glucose-modified zein (GZ) nanoparticles loaded with docetaxel (DTX) (DTX-GNPs) were prepared, characterized, and evaluated in vitro and in vivo for cellular uptake, absorption sites, pharmacokinetics, in vitro distribution, and antitumor effects. Glucose modification significantly enhanced the absorption of DTX-NPs in the jejunum and ileum. The enhanced tumor targeting of GZ-NPs is related to their particle size, surface charge, and glucose modifications.GZ-NPs reduced the toxicity of docetaxel in the liver, kidney, and lung and improved its safety.
Fig.1 Studies on the cellular uptake mechanism of DTX nanoparticles. (Xing, et al., 2022)
Frequently Asked Questions
- What are the factors that influence intracellular drug metabolism?
- Cell type: drugs are metabolized differently in different cell lines, such as enterocytes, hepatocytes, tumor cells, etc.
- Intracellular substances: transporters, metabolic enzymes, pH, and electrochemical gradients in the cell are important factors affecting drug metabolism.
- The nature of the drug itself: e.g., drug polarity, dosage form, presence or absence of chemical modifications, and surface charge affects its metabolism in cells.
- What are the methods used to study cellular metabolic kinetics?
Our company often uses electron microscopy, flow cytometry, laser scanning confocal microscopy, HPLC, and LC-mass spectrometry (LC-MS) to analyze cellular metabolic kinetics.
Based on a high-quality GlycoNano™ platform, CD BioGlyco provides professional glyconanoparticle pharmacokinetic study services including absorption, distribution, metabolism, excretion, and half-life studies. If you are interested in our preclinical studies, please feel free to contact us.
Reference
- Xing, Y.; et al. Glucose-modified zein nanoparticles enhance oral delivery of docetaxel. Pharmaceutics. 2022, 14(7): 1361
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform





